New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2013
10:04 EDTMGLN, COG, SWN, MWV, ASH, TWO, KRA, GMAN, ZIOPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Ashland (ASH) downgraded to Neutral from Buy at Longbow... Cabot Oil & Gas (COG) downgraded to Hold from Buy at Stifel... Gordmans Stores (GMAN) downgraded to Neutral from Overweight at Piper Jaffray... Kraton Performance (KRA) downgraded to Perform from Outperform at Oppenheimer... Magellan Health (MGLN) downgraded to Market Perform from Outperform at Raymond James... MeadWestvaco (MWV) downgraded to Neutral from Buy at UBS... Southwestern Energy (SWN) downgraded to Hold from Buy at Stifel... Ziopharm (ZIOP) downgraded to Underperform from Market Perform at BMO Capital... Two Harbors (TWO) downgraded to Neutral from Buy at Compass Point... Cabot Oil & Gas (COG) downgraded to Hold from Buy at Stifel... Southwestern Energy (SWN) downgraded at Stifel.
Sign up for a free trial to see the rest of the stories you've been missing.
October 6, 2015
14:45 EDTMGLNMagellan Health risk/reward balanced at current levels, says Raymond James
Subscribe for More Information
09:48 EDTMGLNMagellan Health Florida program can still be profitable, says Jefferies
Subscribe for More Information
08:14 EDTMGLNMagellan Health Florida rate significantly lower than expected, says Leerink
Leerink analyst Ana Gupte calls the final rate released by the Florida Medicaid Agency as significantly lower than expected for Magellan Health (MGLN). Gupte sees 10c-20c in earnings per share downside for FY15 and 30c-60c downside in FY16. The rate disappointment is Magellan-specific as Centene (CNC) indicated that the rate increase for it is in line with its expectation, the analyst tells investors in a research note. The rate disappointment is also an additional 2016 headwind for Magellan after the Iowa contract, she adds. The analyst keeps a Market Perform rating on Magellan.
08:12 EDTMGLNMagellan Health sees 3% lower blended rates for unit due to AHCA rate change
Subscribe for More Information
October 5, 2015
10:10 EDTKRAKraton Performance management to meet with JPMorgan
Subscribe for More Information
07:17 EDTSWNIndependent Petroleum Association of America to hold a conference
IPAA--OGIS is being held in San Francisco on October 5-6.
September 29, 2015
12:26 EDTCOGCabot Oil & Gas backs FY15 production growth view 10%-18%
Information from company slides presentation.
10:48 EDTZIOPOptions with increasing implied volatility
Subscribe for More Information
September 28, 2015
16:04 EDTZIOPIntrexon to collaborate with Ziopharm for graft-versus-host disease
Intrexon (XON) announced it has formed a new exclusive channel collaboration with Ziopharm Oncology (ZIOP) for the treatment and prevention of graft-versus-host disease. The collaboration will focus on addressing the underlying pathologies of GvHD through engineered cell platforms to express and deliver interleukin-2. The companies plan to pursue engineered cell therapy strategies, used either separately or in combination, for targeted treatment of GvHD. The first approach is infusion of regulatory T cells conditionally expressing IL-2 utilizing Intrexon's proprietary gene control approaches such as its RheoSwitch platform. The second is deployment of orally-delivered microbe-based ActoBiotics therapeutics expressing IL-2 to modulate immune function. Under the terms of the agreement, Intrexon will receive a technology access fee of $10M in cash and reimbursement for all research and development costs. The agreement also provides for equal sharing of operating profits.
07:14 EDTZIOPZIOPHARM names Eagle Pharmaceuticals CEO to board
Subscribe for More Information
06:08 EDTKRAKraton Performance to host conference call
Subscribe for More Information
06:04 EDTKRAKraton Performance agrees to acquire Arizona Chemical Holdings for $1.37B
Kraton Performance announced that it has entered into a definitive agreement to acquire all of the capital stock of privately held Arizona Chemical Holdings Corporation for a cash purchase price of $1.37B. Arizona Chemical is a global producer of high-value performance products and specialty chemicals derived from non-hydrocarbon, renewable raw materials. Arizona Chemical's end use market exposure is highly complementary with that of Kraton, particularly in markets such as adhesives, roads and construction, coatings and oilfield chemicals. The $1.37B base purchase price is subject to adjustment for cash and indebtedness at closing, as well as an adjustment for working capital and other items. Kraton will finance the purchase price through debt facilities that have been committed by Credit Suisse Securities, Nomura Securities International, Inc., and Deutsche Bank Securities, Inc. The seller of Arizona Chemical is AZC Holding Company, LLC, which is principally owned by investment funds managed by American Securities LLC. The acquisition is subject to regulatory and other customary approvals and conditions and is currently expected to close in late 2015 or early 2016. the acquisition is expected to result in $65M of pre-tax run rate synergies and is expected to be accretive to EPS by approximately $1.40 per share in the first full year of combined operation.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use